Streetbeat News

Equity Actions

SAP

SAP's (NYSE:SAP) short interest has increased by 14.29% since the last report, with 2.85 million shares sold short, representing 0.24% of available shares. It would take about 3.49 days to cover all short positions. While an increase in short interest can indicate bearish sentiment, SAP has less short interest compared to its peers, with an average of 3.58% in the peer group. This rise in short interest does not necessarily predict a near-term price drop.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 1:15 pm

TWST

Twist Bioscience has announced the appointment of Adam Laponis as its new Chief Financial Officer. This strategic move could signal a strengthening of the company's financial leadership, potentially impacting investor confidence and future financial planning.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 1:13 pm

CPRX

Catalyst Pharmaceuticals, Inc. (CPRX) has priced a public offering of 10 million shares at $15 each, aiming to raise $150 million before fees. The underwriters have an option to buy an additional 1.5 million shares. The offering is set to close around January 9, 2024. Catalyst intends to use the proceeds for potential acquisitions of new product candidates and general corporate purposes. BofA Securities, Citigroup, Piper Sandler & Co., Cantor, and Truist Securities are the bookrunners, with H.C. Wainwright & Co. and Oppenheimer & Co. as co-lead managers.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 1:09 pm

CPRX

Catalyst Pharmaceuticals has announced the pricing of a public offering of its common stock, aiming to raise total gross proceeds of $150 million. The offering is expected to increase the number of shares available in the market, which could potentially dilute the value of existing shares.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 1:09 pm

DNB

Over the past quarter, 5 analysts have provided diverse opinions on Dun & Bradstreet Hldgs (NYSE:DNB), with recent ratings showing 1 bullish and 2 neutral stances. The average 12-month price target is $14.26, with a high of $18.00 and a low of $10.30, marking an increase from the previous average of $13.67. Analysts from Raymond James, Truist Securities, Goldman Sachs, JP Morgan, and Needham have made various adjustments to their ratings and price targets. Dun & Bradstreet Hldgs is a provider of business decisioning data and analytics, with a lower market capitalization compared to industry averages, a revenue growth rate of 5.79%, a net margin of 0.75%, an ROE of 0.13%, an ROA of 0.05%, and a debt-to-equity ratio of 1.08.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 1:00 pm

REXR

Analysts have provided mixed evaluations for Rexford Industrial Realty (NYSE:REXR) over the last three months, with recent ratings showing a shift towards a more neutral stance. The average 12-month price target is now $55.4, a slight decrease from the previous $56.33. Rexford Industrial Realty, a REIT focusing on industrial properties in Southern California, has shown strong revenue growth and net margin but below-average ROE and ROA. The company's financial health appears stable with a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 1:00 pm

BOXL

Boxlight Corporation has announced the departure of Michael Pope as CEO. Dale Strang, an independent director, has been appointed as Interim CEO. Additionally, Wayne Jackson has been appointed as the new Chairman of the Board.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 12:19 pm

EU

EnCore Energy has issued a total of 7.58 million common shares under its at-the-market controlled equity offering program during the period from October 1, 2023, to December 31, 2023.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 12:17 pm

MAN

ManpowerGroup (NYSE:MAN) received mixed analyst ratings in the latest quarter, with 3 indifferent and 1 somewhat bearish. The average 12-month price target is $76.00, down from the previous $83.33. Analysts from Exane BNP Paribas, Truist Securities, BMO Capital, and UBS have adjusted their price targets and ratings, reflecting changes in market conditions and company performance. ManpowerGroup faces challenges with revenue growth, net margin, ROE, and ROA, all below industry standards, but has a positive debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 12:00 pm

CVS

CVS Health announced that it entered into a $3 billion fixed dollar accelerated share repurchase (ASR) transaction during Q4, which became effective on January 3, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 11:57 am